RECURSION PHARMACEUTICALS-A (RXRX) Institutional Ownership and Insiders Activity
RECURSION PHARMACEUTICALS-A (RXRX) is widely held by institutional investors, with 340 firms reporting positions valued at approximately $1.57B based on SEC Form 13F filings for the quarter ended September 30, 2026.
Blackrock, Inc. is the largest disclosed holder, reporting approximately $220.87M in RXRX holdings in its latest filing.
Recent insider activity includes 12 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.
Institutional Holders
340
Total Reported Value
$1.57B
Largest Holder
Blackrock, Inc.
Largest Position
$220.87M
Insider Transactions (90d)
12
Latest Filing Quarter
Q3 2026
New Institutional Positions
64
Funds Exiting Positions
58
Top Institutional Owners
View allInvestorReported Balance
- Blackrock, Inc.$220.87M
- ARK Invest$184.80M
- Vanguard Portfolio Management Llc$147.90M
- State Street Corp$123.90M
- Vanguard Capital Management Llc$95.01M
RXRX News
All news- Mic Capital Management UK LLP Activity Analysis for Q2 2026
Aug 11, 2026 · valut.ai
Related RXRX Institutional Insights:
- RXRX 13F Institutional Holders
- RXRX Superinvestors
- RXRX Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- RXRX Insider Trading & SEC Form 4 Activity
- RXRX Articles
- Top Institutional Investor Stock Rankings